Nektar Therapeutics Overview
Nektar Therapeutics Discounted Cash Flow
DCF Analysis for NKTR.
Get informed when a big investor buys or sells
+ FollowFair Value
$-30.22
Current Fair Value
$-30.22
↓ 149.4% Downside
Overvalued by 149.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison